Q3 2024 Market Commentary
In the words of Bob Marley (on the 1977 album Exodus) “Don’t worry about a thing, ‘cos every little thing’s gonna be alright.” Certainly, whilst UK private investors fret about..
Equity
How to prepare for the Budget Countdown
Since the new administration took power, we have heard very little about the growth agenda which was an important part of the election campaign. Instead….
Q2 2024 Market Commentary
The second quarter was generally benevolent for equities. As the chart below shows, the US continued to be the outperformer, but this was rather more broadly based than in the recent past…
Q1 2024 Market Commentary
We have commented in the past about the futility of forecasting and the importance of understanding where we are – in the words of the great investment guru, Fatboy Slim – right here, right now.
Q4 2023 Market Commentary
This is the season of forecasts. A bit like midges in the Scottish Highlands, they come around every year, and are about as much use.
Q3 2023 Market Commentary
Over the last year there has been a slow reawakening of interest from private investors and wealth managers in investing in bonds.
Is taking on debt or giving away equity the best way to fund growth?
LGB’s CEO Andrew Boyle recently contributed to a debate in Business Lender’s Money Supplement on the best way to fund growth. Debt Benefits of selecting …
Mous Products Ltd – Equity Raise – June 2021
We are pleased to announce the completion of a £1.4m equity raise for Mous Products Ltd (“Mous”). Mous is a direct-to-consumer (“D2C”) tech accessories brand based in …
Arecor Therapeutics Plc IPO
Clients of LGB Investments were invited to participate in the partially EIS-qualifying initial public offering (IPO) for Arecor Therapeutics Plc (LON:AREC). As part of the …
MaxCyte announces £40 million subscription
MaxCyte, Inc. (LSE: MXCT, MXCL), a global cell-engineering and life sciences company, has raised gross proceeds of £40 million (US$55 million) through a private placement …
